You are visiting a Controlled Access Programme (CAP) portal designed to meet European Medicines Agency (EMA) and Health Products Regulatory Authority (HPRA) requirements
This site contains important safety information for Republic of Ireland based Healthcare Professionals who may wish to prescribe Finteplaâ–¼ (fenfluramine) in the Republic of Ireland
Educational material for patients can also be accessed here
Please select the appropriate box below to continue